Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion
NCT05461092Phase 1Recruiting
- Sponsor
- University of Iowa
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of bupivacaine in pain and delirium (2 arms), sponsored by University of Iowa. Primary endpoints: Numerical Rating Score at 12 weeks, Daily Pain Trajectory at 30 days and 11 more. Started Jan 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
paindelirium
Beyond the preview
Go deeper on NCT05461092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05461092.